These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18272292)

  • 1. Developmental regulation of leucine-rich repeat kinase 1 and 2 expression in the brain and other rodent and human organs: Implications for Parkinson's disease.
    Westerlund M; Belin AC; Anvret A; Bickford P; Olson L; Galter D
    Neuroscience; 2008 Mar; 152(2):429-36. PubMed ID: 18272292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice.
    Giesert F; Hofmann A; Bürger A; Zerle J; Kloos K; Hafen U; Ernst L; Zhang J; Vogt-Weisenhorn DM; Wurst W
    PLoS One; 2013; 8(5):e63778. PubMed ID: 23675505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2 expression linked to dopamine-innervated areas.
    Galter D; Westerlund M; Carmine A; Lindqvist E; Sydow O; Olson L
    Ann Neurol; 2006 Apr; 59(4):714-9. PubMed ID: 16532471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and localization of Parkinson's disease-associated leucine-rich repeat kinase 2 in the mouse brain.
    Higashi S; Moore DJ; Colebrooke RE; Biskup S; Dawson VL; Arai H; Dawson TM; Emson PC
    J Neurochem; 2007 Jan; 100(2):368-81. PubMed ID: 17101029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of PINK1 and LRRK2 in rat and mouse brain.
    Taymans JM; Van den Haute C; Baekelandt V
    J Neurochem; 2006 Aug; 98(3):951-61. PubMed ID: 16771836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical localization of leucine-rich repeat kinase 2 in mouse brain.
    Melrose H; Lincoln S; Tyndall G; Dickson D; Farrer M
    Neuroscience; 2006; 139(3):791-4. PubMed ID: 16504409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions?
    Civiero L; Bubacco L
    Biochem Soc Trans; 2012 Oct; 40(5):1095-101. PubMed ID: 22988872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.
    Li X; Tan YC; Poulose S; Olanow CW; Huang XY; Yue Z
    J Neurochem; 2007 Oct; 103(1):238-47. PubMed ID: 17623048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional responses to loss or gain of function of the leucine-rich repeat kinase 2 (LRRK2) gene uncover biological processes modulated by LRRK2 activity.
    Nikonova EV; Xiong Y; Tanis KQ; Dawson VL; Vogel RL; Finney EM; Stone DJ; Reynolds IJ; Kern JT; Dawson TM
    Hum Mol Genet; 2012 Jan; 21(1):163-74. PubMed ID: 21972245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic and redundant regulation of LRRK2 and LRRK1 expression.
    Biskup S; Moore DJ; Rea A; Lorenz-Deperieux B; Coombes CE; Dawson VL; Dawson TM; West AB
    BMC Neurosci; 2007 Nov; 8():102. PubMed ID: 18045479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen.
    Maekawa T; Kubo M; Yokoyama I; Ohta E; Obata F
    Biochem Biophys Res Commun; 2010 Feb; 392(3):431-5. PubMed ID: 20079710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury.
    Boddu R; Hull TD; Bolisetty S; Hu X; Moehle MS; Daher JP; Kamal AI; Joseph R; George JF; Agarwal A; Curtis LM; West AB
    Hum Mol Genet; 2015 Jul; 24(14):4078-93. PubMed ID: 25904107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents.
    West AB; Cowell RM; Daher JP; Moehle MS; Hinkle KM; Melrose HL; Standaert DG; Volpicelli-Daley LA
    J Comp Neurol; 2014 Aug; 522(11):2465-80. PubMed ID: 24633735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain.
    Simón-Sánchez J; Herranz-Pérez V; Olucha-Bordonau F; Pérez-Tur J
    Eur J Neurosci; 2006 Feb; 23(3):659-66. PubMed ID: 16487147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease.
    Taylor JP; Hulihan MM; Kachergus JM; Melrose HL; Lincoln SJ; Hinkle KM; Stone JT; Ross OA; Hauser R; Aasly J; Gasser T; Payami H; Wszolek ZK; Farrer MJ
    Neurogenetics; 2007 Apr; 8(2):95-102. PubMed ID: 17225181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?
    Gillardon F
    J Neurochem; 2009 Sep; 110(5):1514-22. PubMed ID: 19545277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain.
    Higashi S; Biskup S; West AB; Trinkaus D; Dawson VL; Faull RL; Waldvogel HJ; Arai H; Dawson TM; Moore DJ; Emson PC
    Brain Res; 2007 Jun; 1155():208-19. PubMed ID: 17512502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and pathological characterization of Lrrk2.
    Giasson BI; Covy JP; Bonini NM; Hurtig HI; Farrer MJ; Trojanowski JQ; Van Deerlin VM
    Ann Neurol; 2006 Feb; 59(2):315-22. PubMed ID: 16437584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selective LRRK2 kinase inhibition on nonhuman primate lung.
    Fuji RN; Flagella M; Baca M; Baptista MA; Brodbeck J; Chan BK; Fiske BK; Honigberg L; Jubb AM; Katavolos P; Lee DW; Lewin-Koh SC; Lin T; Liu X; Liu S; Lyssikatos JP; O'Mahony J; Reichelt M; Roose-Girma M; Sheng Z; Sherer T; Smith A; Solon M; Sweeney ZK; Tarrant J; Urkowitz A; Warming S; Yaylaoglu M; Zhang S; Zhu H; Estrada AA; Watts RJ
    Sci Transl Med; 2015 Feb; 7(273):273ra15. PubMed ID: 25653221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.